Brainstorm Cell Therapeutics, Inc. (BCLI)

1.00 +0.02 (+2.04%) USD  |  OTCM  |  Aug 24, 16:00
More

Brainstorm Cell Therapeutics EPS Estimates for Next Quarter

EPS Estimates for Next Quarter Chart

View EPS Estimates for Next Quarter for BCLI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Estimates for Next Quarter Chart
Start Trial

Historical EPS Estimates for Next Quarter Data

View and export this data back to 2024. Start Trial.
Date Value
August 17, 2026 --
August 14, 2025 --
July 23, 2025 --
May 19, 2025 --
Date Value
April 04, 2025 --
August 14, 2024 --
July 11, 2024 --

Earnings Per Share Estimates Definition

This is the earnings consensus estimate for a given period of time, according to analysts polled by Standard & Poor's.

Read full definition.

EPS Estimates for Next Quarter Range, Past 5 Years

View EPS Estimates for Next Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Estimates for Next Quarter Benchmarks

View EPS Estimates for Next Quarter Benchmarks
Start Trial
NovelStem International Corp. Upgrade
Summit Therapeutics, Inc. Upgrade
Kezar Life Sciences, Inc. Upgrade
Protara Therapeutics, Inc. Upgrade
Clene, Inc. Upgrade

EPS Estimates for Next Quarter Related Metrics

EPS Estimates for Current Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade